Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in t...

Full description

Bibliographic Details
Main Authors: Jacques Loretta, Forth Richard, Snowise Neil G, Lötvall Jan, Busse William W, Bateman Eric D, Woodcock Ashley, Haumann Brett, Bleecker Eugene R
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Respiratory Research
Subjects:
once-daily
ICS
asthma
Online Access:http://respiratory-research.com/content/12/1/132

Similar Items

Similar Items